Rosiglitazone treatment of diabetes mellitus after solid organ transplantation

被引:43
作者
Baldwin, D
Duffin, KE
机构
[1] Rush Presbyterian St Lukes Med Ctr, Endocrinol Sect, Chicago, IL 60612 USA
[2] Hornsby Ku Ring Gai Hosp, Hornsby, NSW, Australia
关键词
D O I
10.1097/01.TP.0000116393.98934.6F
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Diabetes mellitus is a common clinical problem after solid organ transplantation. Whether patients have preexisting diabetes or develop posttransplant diabetes, insulin therapy is usually required. Achieving excellent diabetic control is an important target in reducing the incidence of cardiovascular disease after transplantation. Methods. The authors treated 18 patients with type 2 diabetes after transplantation with rosiglitazone. Eleven patients had preexisting type 2 diabetes and seven patients developed posttransplant diabetes. Rosiglitazone was added to insulin or glyburide to improve elevated hemoglobin Hb A(1C) levels in patients with preexisting diabetes or was used to try to avoid insulin therapy in posttransplant diabetics. Blood levels of cyclosporine, tacrolimus, creatinine, and HbA(1C) were followed for a mean of 381 days (range, 133-718 days). Results. The addition of rosiglitazone did not cause any significant changes in serum creatinine, cyclosporine, or tacrolimus. There were no significant changes in cyclosporine or tacrolimus doses. Mean HbA(1C) improved from 8.1+/-1.5% to 6.9+/-1.3% (P=0.01) in the 18 patients and from 8.6+/-1.5% to 6.7+/-0.5% (P=0.035) in the 7 patients with posttransplant diabetes. All patients with posttransplant diabetes were well controlled without insulin therapy. Conclusions. Rosiglitazone is a safe and effective oral agent for the treatment of diabetes mellitus after solid organ transplantation. It is the first agent to allow successful oral therapy for patients with posttransplant diabetes, and is a well-tolerated alternative to insulin for these patients.
引用
收藏
页码:1009 / 1014
页数:6
相关论文
共 30 条
[1]   THE IMPACT OF CYCLOSPORINE AND COMBINATION IMMUNOSUPPRESSION ON THE INCIDENCE OF POSTTRANSPLANT DIABETES IN RENAL-ALLOGRAFT RECIPIENTS [J].
BOUDREAUX, JP ;
MCHUGH, L ;
CANAFAX, DM ;
ASCHER, N ;
SUTHERLAND, DER ;
PAYNE, W ;
SIMMONS, RL ;
NAJARIAN, JS ;
FRYD, DS .
TRANSPLANTATION, 1987, 44 (03) :376-381
[2]   Effect of troglitazone on cyclosporine whole blood levels [J].
Burgess, SJ ;
Singer, GG ;
Brennan, DC .
TRANSPLANTATION, 1998, 66 (02) :272-272
[3]   Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years [J].
Cosio, FG ;
Pesavento, TE ;
Osei, K ;
Henry, ML ;
Ferguson, RM .
KIDNEY INTERNATIONAL, 2001, 59 (02) :732-737
[4]   New-onset diabetes after transplantation: 2003 International Consensus Guidelines [J].
Davidson, J ;
Wilkinson, A ;
Dantal, J ;
Dotta, F ;
Haller, H ;
Hernández, D ;
Kasiske, BL ;
Kiberd, B ;
Krentz, A ;
Legendre, C ;
Marchetti, P ;
Markell, M ;
van der Woude, FJ ;
Wheeler, DC .
TRANSPLANTATION, 2003, 75 (10) :SS3-SS24
[5]   Islet cell damage associated with tacrolimus and cyclosporine: Morphological features in pancreas allograft biopsies and clinical correlation [J].
Drachenberg, CB ;
Klassen, DK ;
Weir, MR ;
Wiland, A ;
Fink, JC ;
Bartlett, ST ;
Cangro, CB ;
Blahut, S ;
Papadimitriou, JC .
TRANSPLANTATION, 1999, 68 (03) :396-402
[6]  
Frantz RP, 1998, J HEART LUNG TRANSPL, V17, P1037
[7]   INHIBITION BY CYCLOSPORINE OF INSULIN-SECRETION - A BETA-CELL-SPECIFIC ALTERATION OF ISLET TISSUE FUNCTION [J].
GILLISON, SL ;
BARTLETT, ST ;
CURRY, DL .
TRANSPLANTATION, 1991, 52 (05) :890-895
[8]  
Golling M, 1996, TRANSPLANT P, V28, P3180
[9]   Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age [J].
Hjelmesaeth, J ;
Hartmann, A ;
Kofstad, J ;
Stenstrom, J ;
Leivestad, T ;
Egeland, T ;
Fauchald, P .
TRANSPLANTATION, 1997, 64 (07) :979-983
[10]   Metabolic cardiovascular syndrome after renal transplantation [J].
Hjelmesæth, J ;
Hartmann, A ;
Midtvedt, K ;
Aakhus, S ;
Stenstrom, J ;
Morkrid, L ;
Egeland, T ;
Tordarson, H ;
Fauchald, P .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (05) :1047-1052